Back to Search Start Over

TGF-β and RAS jointly unmask primed enhancers to drive metastasis.

Authors :
Lee, Jun Ho
Sánchez-Rivera, Francisco J.
He, Lan
Basnet, Harihar
Chen, Fei Xavier
Spina, Elena
Li, Liangji
Torner, Carles
Chan, Jason E.
Yarlagadda, Dig Vijay Kumar
Park, Jin Suk
Sussman, Carleigh
Rudin, Charles M.
Lowe, Scott W.
Tammela, Tuomas
Macias, Maria J.
Koche, Richard P.
Massagué, Joan
Source :
Cell. Oct2024, Vol. 187 Issue 22, p6182-61619. 55438p.
Publication Year :
2024

Abstract

Epithelial-to-mesenchymal transitions (EMTs) and extracellular matrix (ECM) remodeling are distinct yet important processes during carcinoma invasion and metastasis. Transforming growth factor β (TGF-β) and RAS, signaling through SMAD and RAS-responsive element-binding protein 1 (RREB1), jointly trigger expression of EMT and fibrogenic factors as two discrete arms of a common transcriptional response in carcinoma cells. Here, we demonstrate that both arms come together to form a program for lung adenocarcinoma metastasis and identify chromatin determinants tying the expression of the constituent genes to TGF-β and RAS inputs. RREB1 localizes to H4K16acK20ac marks in histone H2A.Z-loaded nucleosomes at enhancers in the fibrogenic genes interleukin-11 (IL11), platelet-derived growth factor-B (PDGFB), and hyaluronan synthase 2 (HAS2), as well as the EMT transcription factor SNAI1 , priming these enhancers for activation by a SMAD4-INO80 nucleosome remodeling complex in response to TGF-β. These regulatory properties segregate the fibrogenic EMT program from RAS-independent TGF-β gene responses and illuminate the operation and vulnerabilities of a bifunctional program that promotes metastatic outgrowth. [Display omitted] • TGF-β and RAS drive expression of EMT and fibrogenic genes that jointly fuel metastasis • Epigenetic determinants segregate different programs within a global TGF-β response • RAS/MAPK-regulated RREB1 primes enhancers for activation by SMAD-recruited INO80 • Targeting RREB1 selectively inhibits LUAD metastasis During carcinoma metastasis, malignant progenitors undergo a TGF-β-dependent EMT associated with fibroblast activation and extracellular matrix remodeling in the tumor microenvironment. RAS-activated RREB1 primes enhancers of EMT and fibrogenic genes in lung adenocarcinoma cells for activation by chromatin remodeling complexes that the TGF-β/SMAD pathway recruits to these enhancers. Inhibiting RREB1 disables this pro-metastatic process. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00928674
Volume :
187
Issue :
22
Database :
Academic Search Index
Journal :
Cell
Publication Type :
Academic Journal
Accession number :
180531979
Full Text :
https://doi.org/10.1016/j.cell.2024.08.014